Bharat Biotech announces equitable malaria vaccine pricing with Gavi and UNICEF to protect 1 million more children

The agreement, executed by UNICEF and financially backed by Gavi, the Vaccine Alliance, will cut the price of the vaccine by approximately 40 per cent. This will generate around US$50 million in savings to child immunisation programmes between 2027 and 2029 and reach up to one million more children with the full four-dose course.